Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Significance Statement: Studies suggest that autophagy may be protective in kidney diseases, but understanding how the autophagic process is specifically altered in each disorder is important for applying it therapeutically. On the basis of the observation that autophagy in proximal tubule epithelial cells is mainly regulated by insulin, the authors used diabetic mouse models to investigate whether types 1 and 2 diabetic nephropathy differ in autophagic status. They found distinct patterns of autophagic dysregulation involved in the pathophysiology of types 1 and 2 diabetic nephropathy, with autophagy induction suppressed in the type 2 diabetic kidney (even under starvation) and basal autophagic activity enhanced in the type 1 diabetic kidney (even under fed conditions). They also provide evidence that activated autophagy protects the type 1 diabetic kidney, whereas autophagic suppression jeopardizes the kidney in type 2 diabetes. Background: Evidence of a protective role of autophagy in kidney diseases has sparked interest in autophagy as a potential therapeutic strategy. However, understanding how the autophagic process is altered in each disorder is critically important in working toward therapeutic applications. Methods: Using cultured kidney proximal tubule epithelial cells (PTECs) and diabetic mouse models, we investigated how autophagic activity differs in type 1 versus type 2 diabetic nephropathy. We explored nutrient signals regulating starvation-induced autophagy in PTECs and used autophagy-monitoring mice and PTEC-specific autophagy-deficient knockout mice to examine differences in autophagy status and autophagy’s role in PTECs in streptozotocin (STZ)-treated type 1 and db / db type 2 diabetic nephropathy. We also examined the effects of rapamycin (an inhibitor of mammalian target of rapamycin [mTOR]) on vulnerability to ischemia-reperfusion injury. Results: Administering insulin or amino acids, but not glucose, suppressed autophagy by activating mTOR signaling. In db / db mice, autophagy induction was suppressed even under starvation; in STZ-treated mice, autophagy was enhanced even under fed conditions but stagnated under starvation due to lysosomal stress. Using knockout mice with diabetes, we found that, in STZ-treated mice, activated autophagy counteracts mitochondrial damage and fibrosis in the kidneys, whereas in db / db mice, autophagic suppression jeopardizes kidney even in the autophagy-competent state. Rapamycin-induced pharmacologic autophagy produced opposite effects on ischemia-reperfusion injury in STZ-treated and db/db mice. Conclusions: Autophagic activity in PTECs is mainly regulated by insulin. Consequently, autophagic activity differs in types 1 and 2 diabetic nephropathy, which should be considered when developing strategies to treat diabetic nephropathy by modulating autophagy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy in the proximal tubules seemed to be mainly regulated by insulin, instead of amino acids or glucose, which activated the mTOR pathway.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Of note, using cultured PTECs and different diabetic mouse models, researchers have suggested that type 1 and type 2 DKD, modelled by STZ injection and the db/db mouse models, respectively, differ in autophagic responses154.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Notably, pretreatment with rapamycin caused stagnation of autophagy and exaggerated kidney IRI in STZ-injected mice, whereas rapamycin reactivated autophagy and attenuated kidney IRI in db/db mice154.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
In the citing paper
“Therefore, autophagy was suppressed in db/db mice owing to hyperactive mTOR, whereas high levels of autophagy were induced in STZ-injected mice, which eventually led to lysosomal stress.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [154]
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Antimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Autophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583 · cited 2×
“To compare the inhibitory effects of glucose, insulin, or amino acid treatment in cultured PTECs on autophagy, cells were starved in HBSS for 24 hours followed by incubation for 1 hour with (1) low-glucose DMEM (100 mg/dl glucose; Gibco, Grand Island, NY) containing 0.1% FBS, (2) low-glucose DMEM containing 10% FBS, (…”
InfluentialHomeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105
Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.004 · Cited by 1,489
Autophagy gone awry in neurodegenerative diseases
Wong, E., & Cuervo, A. M. (2010) · Nature Neuroscience · doi:10.1038/nn.2575 · Cited by 815
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Ma, Z., Li, L., Livingston, M. J., Zhang, D., Mi, Q., Zhang, M., Ding, H.-F., Huo, Y., Mei, C., & Dong, Z. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135536 · Cited by 220
“(23) consistently demonstrated autophagy dysfunction in both STZ-induced type 1 and db/db type 2 diabetic mice.”
BackgroundMitochondrial dysfunction in diabetic tubulopathy
Yao, L., Liang, X., Qiao, Y., Chen, B., Wang, P., & Liu, Z. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155195 · Cited by 186
Jiang, N., Zhao, H., Han, Y., Li, L., Xiong, S., Zeng, L., Xiao, Y., Wei, L., Xiong, X., Gao, P., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12909 · Cited by 156
Packer, M. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020010010 · Cited by 123
Xu, J., Kitada, M., Ogura, Y., Liu, H., & Koya, D. (2021) · Cells · doi:10.3390/cells10061457 · Cited by 131
“However, a recent study indicated that autophagy activity has the opposite manifestation in type 1 and type 2 diabetes mellitus (T1DM and T2DM) [45].”
BackgroundInfluentialPacker, M. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.05.019 · Cited by 131
Autophagy in diabetic nephropathy: a review
Koch, E. A. T., Nakhoul, R., Nakhoul, F. M., & Nakhoul, N. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02545-4 · Cited by 118
Packer, M. (2020) · Circulation · doi:10.1161/circulationaha.119.045561 · Cited by 121
Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases
Huynh, C. Q., Ryu, J., Lee, J., Inoki, A., & Inoki, K. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00648-y · Cited by 118
Pathological mechanisms of kidney disease in ageing
Yamamoto, T., & Isaka, Y. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00868-4 · Cited by 113
“This hypothesis is supported by the finding that dysregulation of autophagy not only promotes CKD but also increases AKI vulnerability 71,77,113,114 , probably by reducing the ability of kidneys to respond to stressors.”
Self-citationZhong, Y., Luo, R., Liu, Q., Zhu, J., Lei, M., Liang, X., Wang, X., & Peng, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112697 · Cited by 79
Packer, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13961 · Cited by 83
“The accumulation of intracellular glucose and lipid intermediates acts to suppress autophagic flux, and hyperinsulinaemia further impairs the lysosome-mediated degradation of cellular constituents.(33) Podocytes show high rates of autophagy under basal conditions, suggesting that autophagy is a fundamental self-repair…”
BackgroundExosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy
Chen, J., Zhang, Q. H., Liu, D., & Liu, Z. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154834 · Cited by 76
ZIP14 is involved in iron deposition and triggers ferroptosis in diabetic nephropathy
Wu, K., Fei, L., Wang, X., Yan, L., Liu, Y., Xu, W., Chen, J., Zhu, E., Zhong, M., Huang, M., et al. (2022) · Metallomics · doi:10.1093/mtomcs/mfac034 · Cited by 75
Liu, X., Jiang, L., Zeng, H.-X., Gao, L., Guo, S., Chen, C., Liu, X., Zhang, M., Ma, L., Li, Y., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2286128 · Cited by 78
“The important role of autophagy in the maintenance of renal function has been elucidated in specific autophagy deficient mice [34].”
BackgroundJiang, X.-S., Xiang, X.-Y., Chen, X., He, J., Liu, T., Gan, H., & Du, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2594-x · Cited by 71
González, C. D., Negueruela, M. P. C., Santamarina, C. N., Resnik, R., & Vaccaro, M. I. (2021) · Cells · doi:10.3390/cells10092497 · Cited by 65
“It is worth considering these roles of autophagy in the kidneys when helping patients through the development of innovative therapeutic strategies to delay or prevent nephropathy [95].”
BackgroundTFEB-mediated lysosomal exocytosis alleviates high-fat diet–induced lipotoxicity in the kidney
Nakamura, J., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Minami, S., Takahashi, A., Matsuda, J., Sakai, S., Yonishi, H., Maeda, S., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162498 · Cited by 60
Self-citationLysosomal dysfunction–induced autophagic stress in diabetic kidney disease
Zheng, H., Zhang, X., Guo, J., Zhang, W., Ai, S., Zhang, F., Wang, Y., & Liu, W. J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15301 · Cited by 57
Ruby, Gifford, C. C., Pandey, R. P., Raj, V., Sabbisetti, V. S., & Ajay, A. K. (2023) · Cells · doi:10.3390/cells12030412 · Cited by 62
“function even in the autophagy-competent condition [81].”
Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection
Lee, J., Tsogbadrakh, B., Yang, S., Ryu, H., Kang, E., Kang, M., Kang, H. G., Ahn, C., & Oh, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.040 · Cited by 54
Chen, D., Xu, R., Zhou, J., Chen, J., Wang, L., Liu, X., Liang, C.-L., Liu, B., Lu, R., Wu, J., et al. (2019) · Food & Function · doi:10.1039/c9fo00957d · Cited by 47
Autophagy in kidney disease: Advances and therapeutic potential
Bhatia, D., & Choi, M. E. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.01.008 · Cited by 53
Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells
Matsuda, J., Takahashi, A., Takabatake, Y., Sakai, S., Minami, S., Yamamoto, T., Fujimura, R., Namba-Hamano, T., Yonishi, H., Nakamura, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1712107 · Cited by 44
“83 mU/g BW human insulin (Lilly, Humulin R, U100) as previously described [37].”
MethodSelf-citationDysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications
Sehrawat, A., Mishra, J., Mastana, S. S., Navik, U., Bhatti, G. K., Reddy, P. H., & Bhatti, J. S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166666 · Cited by 50
Ma, X., & Wang, Q. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1336 · Cited by 47
“Consistent with our result, a previous study indicated that tubule epithelial cell autophagy was defective in both types of diabetes at early and advanced stages and that autophagy may play a protective role in diabetes [25].”
ResultUnraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and Immunometabolism
Narongkiatikhun, P., Choi, Y. J., Hampson, H. E., Gotzamanis, J., Zhang, G., van Raalte, D. H., de Boer, I. H., Nelson, R. G., Tommerdahl, K. L., McCown, P. J., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.019 · Cited by 45
A minireview: Role of AMP-activated protein kinase (AMPK) signaling in obesity-related renal injury
Zhuo, L., Li, J. X., Miao, X., Cui, W., Miao, L., & Cai, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118828 · Cited by 45
FGF21 and autophagy coordinately counteract kidney disease progression during aging and obesity
Minami, S., Sakai, S., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., Nakamura, J., Maeda, S., et al. (2023) · Autophagy · doi:10.1080/15548627.2023.2259282 · Cited by 39
“We have clarified that autophagy in PTECs protects them from acute kidney injury (AKI) [7] and prevents CKD progression during various chronic conditions including aging and obesity [8–11].”
BackgroundSelf-citationThe role of autophagy in the treatment of type II diabetes and its complications: a review
Zhao, X., Bie, L., Pang, D.-R., Li, X., Yang, L., Chen, D., Wang, Y.-R., & Gao, Y. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1228045 · Cited by 41
“During the course of diabetes, autophagy in proximal tubular epithelial cells undergoes signi fi cant changes (82, 92 – 94).”
BackgroundAdvances and perspective on animal models and hydrogel biomaterials for diabetic wound healing.
Hu, Y., Xiong, Y., Tao, R., Xue, H., Chen, L., Lin, Z., Panayi, A. C., Mi, B., & Liu, G. (2022) · PubMed Central · doi:10.12336/biomatertransl.2022.03.003 · Cited by 54
Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy
Wang, Y., Zhao, H., Wang, Q., Zhou, X., Lu, X., Liu, T., Zhan, Y., & Li, P. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9030893 · Cited by 33
“Moreover, further study indicated that inhibition of mTORC1 activity by rapamycin treatment could attenuate apoptosis and fibrosis of kidney cortexes in db/db mice by restoring autophagy [28].”
BackgroundYAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease
Ye, S., Zhang, M., Zheng, X., Li, S., Fan, Y., Wang, Y., Peng, H., Chen, S., Yang, J., Li, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103435 · Cited by 40
“Kidney has a higher rate of mitophagy compared to other organs [56], and disruption of mitophagy may increase the need to use less favorable fuel sources such as glucose within tubule cells, leading to glucotoxicity in DKD [12,57].”
PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization
Chen, M., Lin, W., Ye, R., Yi, J., & Zhao, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.753194 · Cited by 33
“Mice were housed in box cages, maintained on a 12 h light/12 h dark cycle, and fed a chow diet ad libitum (Sakai et al., 2019).”
MethodÖzkan, S., Işıldar, B., Erçin, M., Gezginci-Oktayoğlu, S., Konukoğlu, D., Neşetoğlu, N., Öncül, M., & Koyutürk, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03121-6 · Cited by 32
“In addition, dysregulation of the autophagic mechanism plays an important role in the development of DM-related renal tubule damage [15, 16].”
BackgroundInfluentialMatsui, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba‐Hamano, T., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Nakamura, J., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2410621 · Cited by 31
“Moreover, empagliflozin may represent a promising therapeutic approach to other kidney conditions, such as kidney aging, DKD, and phosphate toxicity, in which autophagic stagnation is also observed [22,43,44].”
Self-citationQiDiTangShen Granules Activate Renal Nutrient-Sensing Associated Autophagy in db/db Mice
Wang, X., Zhao, L. D., Ajay, A. K., Jiao, B., Zhang, X., Wang, C., Gao, X. J., Yuan, Z., Liu, H., & Liu, W. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01224 · Cited by 27
Rosas, L., Rodríguez‐Muñoz, R., Namorado, M. C., Missirlis, F., del Valle‐Mondragón, L., Sánchez-Mendoza, A., Reyes-Sánchez, J. L., & Cervantes-Pérez, L. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.119003 · Cited by 25
The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
Kourtidou, C., & Τζιόμαλος, Κ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24066007 · Cited by 29
“Insulin also impairs autophagic activity in proximal tubule epithelial cells [24].”
BackgroundMinami, S., Yamamoto, T., Yamamoto‐Imoto, H., Isaka, Y., & Hamasaki, M. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.02.005 · Cited by 26
Self-citationGu, H., Li, J., & Ni, Y. (2023) · Environmental Toxicology · doi:10.1002/tox.23890 · Cited by 21
“cellular aging characteristics, including renal function loss, mitochondrial damage, nuclear DNA damage and renal fibrosis, and activation of autophagy can repair mitochondrial damage and fibrosis in the kidney.(13,14) In addition, poor renal tissue repair after acute kidney injury is also an important factor causing…”
BackgroundYuan, D., Li, H., Dai, W., Zhou, X., Zhou, W., & He, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167022 · Cited by 19
Zhou, R., Zhang, Z., Li, X., Duan, Q., Miao, Y., Zhang, T., Wang, M., Li, J., Zhang, W., Wang, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041668 · Cited by 21
“Several studies have demonstrated that insulin inhibits autophagy [42,43].”
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes
Choi, Y. J., Richard, G. M., Zhang, G., Hodgin, J. B., Demeke, D., Yang, Y., Schaub, J. A., Tamayo, I. M., Gurung, B. K., Naik, A. S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci183984 · Cited by 27
Defective autophagy and AMPK inactivation drive ferroptosis in diabetic kidney disease
Matsui, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba‐Hamano, T., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Nakamura, J., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06612-2 · Cited by 24
“2) [19], we subjected 12-week-old db / m and db / db mice to ischaemia– reperfusion injury.”
Self-citationWang, X., Su, W., Ma, M., Zhu, L., Gao, R., Qin, C., Shao, S., Gao, D., Gao, J., & Zhang, Z. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0072 · Cited by 18
d-Alanine Affects the Circadian Clock to Regulate Glucose Metabolism in the Kidney
Sakai, S., Tanaka, Y., Tsukamoto, Y., Kimura‐Ohba, S., Hesaka, A., Hamase, K., Hsieh, C.-L., Kawakami, E., Ono, H., Yokote, K., et al. (2023) · Kidney360 · doi:10.34067/kid.0000000000000345 · Cited by 16
Self-citationNakamura, M., Satoh, N., Horita, S., & Nangaku, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015204 · Cited by 20
“In T1D, autophagic activity was enhanced and more protective than expected because of hyperglycemia and low insulin; in contrast, in T2D, hyperinsulinemia suppressed autophagy induction (Sakai et al., 2019).”
BackgroundActive role of amino acid metabolism in early diagnosis and treatment of diabetic kidney disease
Li, C., Gao, L., Lv, C., Li, Z., Fan, S., Liu, X., Rong, X., Huang, Y., & Liu, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1239838 · Cited by 17
“mTOR is also a key factor in inhibiting autophagy in renal tubular epithelial cells, and Leu may regulate cellular autophagy through the mTOR pathway to mitigate renal injury (55).”
BackgroundLiu, C.-C., Ji, J., Wang, Z., Zhang, X.-J., Ding, L., Zhang, Y., Zhou, Y. W., Zhang, D., Tang, Z.-L., Cao, J., et al. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.08.019 · Cited by 17
Li, L., Zou, J., Zhou, T., Liu, X., Tan, D., Xiang, Q., & Yu, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1578400 · Cited by 22
Ding, T., Song, M., Wang, S., Huang, C., & Pan, T. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108930 · Cited by 15
Diabetic proximal tubulopathy: Can we mimic the disease for in vitro screening of SGLT inhibitors?
Faria, J., Gerritsen, K. G. F., Nguyen, T. Q., Mihaila, S. M., & Masereeuw, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174378 · Cited by 14
Toffoli, B., Tonon, F., Tisato, V., Michelli, A., Zauli, G., Secchiero, P., Fabris, B., & Bernardi, S. (2020) · Clinical Science · doi:10.1042/cs20201004 · Cited by 12
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy
Li, Q., Xu, H., Ma, R.-T., Ma, Y.-Y., & Chen, M. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01641-3 · Cited by 18
“Early in T1DM, autophagy is paradoxically overactivated by HG‑induced oxidative stress, leading to lysosome depletion and autophagy deficiency [7, 8].”
BackgroundInfluentialWang, Y., Zhou, L., Su, W., Huang, F., Zhang, Y., Xia, Z., Xia, Z., & Lei, S. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2408240 · Cited by 11
“It has been shown that diabetes exhibits abnormal autophagy [15], and myocardial I/R injury exacerbates the dysfunctional autophagy activity [16, 17].”
BackgroundDedert, C., Mishra, V., Aggarwal, G., Nguyen, A. D., & Xu, F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.874258 · Cited by 16
“Dysfunctional glucose metabolism from hyperglycemia leads to impaired mitochondrial well-being (Sears and Perry, 2015).”
BackgroundmTORC1 signaling and diabetic kidney disease
Swaroop, V., Ozkan, E. E., Herrmann, L., Thurman, A., Kopasz-Gemmen, O., Kunamneni, A., & Inoki, K. (2024) · Diabetology International · doi:10.1007/s13340-024-00738-1 · Cited by 10
“…as seen in uncontrolled type 1 diabetes mellitus (T1DM) or severe insulin resistance, is likely to lessen the activation of mTORC1 on the lysosomes of kidney cells [6], increased glucose intake may contribute to abnormal mTORC1 activity in the kidney in both type 2 and type 1 diabetes.”
Autophagic stagnation: a key mechanism in kidney disease progression linked to aging and obesity
Yamamoto, T. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02653-4 · Cited by 14
“Indeed, pharmacological inducers of autophagy, such as mTOR inhibitors (e.g., rapamycin), have been shown to exacerbate I/R injury in streptozotocin (STZ)-treated type 1 DKD, where autophagy is stagnated due to lysosomal stress [21].”
Self-citationThe interrelation of galectins and autophagy
Zheng, L., Xia, J., Ge, P., Meng, Y., Li, W., Li, M., Wang, M., Song, C., Fan, Y., & Zhou, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110336 · Cited by 13
MondoA and AKI and AKI-to-CKD Transition
Maeda, S., Sakai, S., Takabatake, Y., Yamamoto, T., Minami, S., Nakamura, J., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000414 · Cited by 9
“13 The autophagic fl ux index is de fi ned as the ratio of the MAP1LC3B-II level in the presence of ba fi lomy-cin A1 to that in the absence of ba fi lomycin A1.”
Self-citationZhang, Y., Yang, B. Y., Tan, M., & Tan, J. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.04.002 · Cited by 8
Saito, Y., Sakamoto, T., Takekuma, Y., Kobayashi, M., Okamoto, K., Shinagawa, N., Shimizu, Y., Kinoshita, I., & Sugawara, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-26454-x · Cited by 11
Nosoko, M., Matsuda, H., Ikeda, J., Abe, M., Masuhiro, Y., Endo, M., Hamet, P., & Tremblay, J. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2024 · Cited by 9
Ding, Z., Yang, C., Zhai, X., Xia, Y., Liu, J., & Yu, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052367 · Cited by 9
“This mirrors observations in diabetic kidneys, where lipotoxicity disrupts lysosomal acidification and autophagosome-lysosome fusion [48,49].”
A novel therapeutic target for kidney diseases: Lessons learned from starvation response
Yamahara, K., Yasuda‒Yamahara, M., & Kume, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108590 · Cited by 7
Nakamura, J., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Minami, S., Sakai, S., Yonishi, H., Maeda, S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.184451 · Cited by 11
Self-citationRenal Cellular Autophagy in Obesity: Boon or Bane?
Ghandriz, R., & Lerman, L. O. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.006 · Cited by 6
Sun, G., Li, X., Liu, P., Wang, Y., Yang, C. L., Zhang, S., Wang, L., & Wang, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336282 · Cited by 7
Saito, Y., Kobayashi, M., Tamaki, S., Nakamura, K., Hirate, D., Takahashi, K., Takekuma, Y., Sakakibara‐Konishi, J., Shimizu, Y., Kinoshita, I., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44477-w · Cited by 8
“Autophagy reportedly protects against CIN 8,13,14 , and its induction at the proximal tubule, where CIN mostly appears, is significantly suppressed in type 2 DM, which all participants met in previous and present studies 4,15 .”
BackgroundResultYoshimura, A., Yamaguchi, T., Kugita, M., Kumamoto, K., Shiogama, K., Ogitsu, N., Yoneda, M., Miura, T., Yoichi, N., & Nagao, S. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.243 · Cited by 8
Suzuki, T., Sato, T., Masuhara, K., Tokusanai, M., Akatsuka, H., Kashikawa, T., & Suzuki, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s430132 · Cited by 5
“A study has reported that in type 2 diabetes, autophagy functioning declines owing to reduced autophagy activity resulting from high insulin levels.(3) Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and a pertinent cause of visual impairment.”
BackgroundShi, Y., Sheng, P., Zhao, Y., Wang, X., Xu, X., & Sun, S. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073255849231030114405 · Cited by 4
Zhang, Z., Xu, Y., Xu, C., Gao, Q., Wu, X., & Wu, T. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00054-y · Cited by 3
“Under sustained hyperglycemia, renal tubular cells exhibit suppressed autophagy flux and downregulated microtubule-associated protein 1 light chain 3 (LC3) expression (Jiang et al. 2020; Sakai et al. 2019).”
Luo, J., Lu, F., Cuciureanu, M. D., Xu, X., Dong, H., & Gong, M. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2620218 · Cited by 4
“…of autophagy were reduced in blood and urine in patients with DKD [76]. the mitophagy flux in the kidney of diabetic mice was significantly inhibited, which accelerated the apoptosis and epithelial-mesenchymal transition of proximal tubular cells, and aggravated renal damage in DKD mice [77,78].”
Li, N., & Zhou, H. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220617153331 · Cited by 5
Yang, T., Yang, Y., Chen, Y., Tang, M., Shi, M., Tian, Y., Yuan, X., Yang, Z., & Chen, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115168 · Cited by 4
Wang, J., Zhao, L., Song, Z., Zhao, S., Zhao, L.-B., Shuang, P.-Z., Liu, F., Li, H.-Z., Wang, X.-L., & Liu, P. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151686 · Cited by 3
Clinical characteristics and treatment compounds of obesity-related kidney injury
Mao, T., Huang, H.-Q., & Zhang, C.-H. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i6.1091 · Cited by 4
Wang, Y., Zhang, L., & Peng, Z. (2023) · Aging · doi:10.18632/aging.205233 · Cited by 2
Guo, J., Zhou, M., Li, S., Wang, C., Fang, Z., Shao, X., Li, A., Zhao, M., Liu, Y., Wang, X., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124062 · Cited by 2
Crosstalk between autophagy and ferroptosis in diabetes
Xie, E., Wei, X., Zheng, Z., Yu, Q., Liu, M., Zhang, H., Jiang, Z., Gao, Y., & Yang, L. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101936 · Cited by 3
“147 Importantly, excessive autophagy activation may induce cardiomyocyte damage, thereby exacerbating the progression of diabetic cardiomyopathy, 148 while concurrently promoting skeletal muscle atrophy associated with DN. 149 Intriguingly, in models of diabetic liver injury, autophagy demonstrates…”
Chai, L., Liu, Z., Zeng, J., Gong, L., Xiang, S., Yu, J. X., Sun, H., Wen, C., Wang, F., Li, N., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01636-8 · Cited by 2
“Animals in the DN group were given an intraperitoneal injection of streptozocin (STZ; 50 mg/kg body weight; Sigma-Aldrich, St. Louis, MO, USA) for 5 consecutive days to induce diabetes [17, 18].”
Autophagy in kidney physiology: from cellular quality control to organ metabolism
Yamamoto, T., Minami, S., & Isaka, Y. (2026) · Autophagy Reports · doi:10.1080/27694127.2026.2622228 · Cited by 2
“Hyperglycemia suppresses autophagic activity in key renal cell types, including PTECs and podocytes, leading to the accumulation of damaged mitochondria, AGEs, and other toxic metabolites-[28,30,61,108] .”
InfluentialSelf-citationOleanolic acid ameliorates podocyte injury by increasing autophagy to attenuate diabetic nephropathy
Cheng, Y., Li, G., Li, Y., Ma, Y., Xia, Y., Zhang, C., & Wang, X. (2026) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgag014 · Cited by 1
Okamoto, K., Saito, Y., Takahashi, K., Takekuma, Y., Sakakibara‐Konishi, J., Narumi, K., Sugawara, M., & Kobayashi, M. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02810-5 · Cited by 1
“In addition, we previously reported that the incidence of CIN was higher in patients with type 2 diabetes, whose renal autophagy induction was significantly suppressed [17], than in those without [5].”
Колесникова, А. А., Колесников, О. Л., & Тарабрина, Ю. О. (2021) · Естественные и Технические Науки · doi:10.37882/2223-2966.2021.09.16
[Diabetes and oral contraceptives].
Aragón, J. A. V., & González, E. L. D. L. O. (1974) · PubMed
Saito, Y., SAKAMOTO, T., Kobayashi, M., Takekuma, Y., Higuchi, I., Okamoto, K., Sakakibara‐Konishi, J., Shimizu, Y., Kinoshita, I., & Sugawara, M. (2024) · In Vivo · doi:10.21873/invivo.13504
Ozkan, S., Işıldar, B., Erçin, M., Gezginci-Oktayoğlu, S., Konukoglu, D., Neşetoğlu, N., Öncül, M., & Koyutürk, M. (2022) · Figshare · doi:10.6084/m9.figshare.20882210
Obiwuma, C., Agbor-Baiyee, B., Ghaderzadeh, S., Mohit, N., Gambhir, K. K., Bobga, B., & Fluitt, M. B. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020223 · Cited by 1
Mitochondrial DNA copy number in diabetic kidney disease: translational prospects and challenges
Lu, L., Cao, Y., Ma, L., & Kong, X. (2026) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2026.2702001 · Cited by 1
Liu, X. Y., Jiang, S., Yang, Z., Shang, S., Li, J., 邹古明, Zhou, C., & Li, W. G. (2026) · Advanced Science · doi:10.1002/advs.76771 · Cited by 1
Das, A., Lalu, E., Awasthi, V., Dhaou, C. B., Hussein, H., Gerhard, G. S., Bahmed, K., Lee, I., Puri, V., & Bouchareb, R. (2026) · Cells · doi:10.3390/cells15191746
“Pharmacologic activation of AMPK (e.g., metformin, AICAR) restores PINK1/Parkin-mediated mitophagy, improves mitochondrial biogenesis, and reduces fibrosis and albuminuria in experimental models [113,114], while mTOR inhibition restores protective autophagy [115].”
Metadata
- Authors
- Sakai, S., Yamamoto, T., Takabatake, Y., Takahashi, A., Namba-Hamano, T., Minami, S., Fujimura, R., Yonishi, H., Matsuda, J., Hesaka, A., Matsui, I., Matsusaka, T., Niimura, F., Yanagita, M., & Isaka, Y.
- Affiliations
- The University of Osaka (JP)
- Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan;
- Institute of Medical Sciences (IN)
- Tokai University (JP)
- Kyoto University (JP)
- Corresponding author
- Takabatake, Yoshitsugu
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2019-04-30
- Volume
- 30
- Issue
- 6
- Pages
- 929-945
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC6551771
- OpenAlex
- W2942855331
- Cited by
- 96
- References
- 57
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 19 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 15 · 2019: 3
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (17K16082)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- autophagy, diabetic nephropathy, type 1 diabetes, type 2 diabetes, proximal tubular epithelial cells, mTOR signaling, insulin, starvation-induced autophagy, lysosomal stress, mitochondrial damage, renal fibrosis, ischemia-reperfusion injury, rapamycin, streptozotocin-induced diabetes, db/db mice
- MeSH terms
- Amino Acids, Animals, Autophagy, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Epithelial Cells, Insulin, Kidney Tubules, Proximal, Lysosomes, Mice, Inbred C57BL, Sensitivity and Specificity, Streptozocin, Mice, Knockout, Sirolimus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.